InfuSystem Holdings, Inc. ("InfuSystem") is a provider of infusion pumps and related services to hospitals, oncology practices, surgery centers.

According to the law firm press release, the lawsuit alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) InfuSystem lacked effective internal control over financial reporting; (2) InfuSystem’s financial statements dating back to the beginning of 2015 overstated the estimated accounts receivable collections which in turn overstated revenues and pre-tax income by a corresponding amount; (3) InfuSystem’s financial statements dating back to the beginning of 2015 could no longer be relied upon; and (4) as a result of the foregoing, the InfuSystem’s financial statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On February 17, 2017, the Court appointed Lead Plaintiffs and Counsel. Lead Plaintiff filed an amended Complaint on April 18, 2017. Defendants filed a Motion to Dismiss the amended Complaint on June 19. On December 15, the Court issued an Order granting Defendants' Motions to Dismiss. Plaintiffs were given leave to file an amended Complaint. Plaintiffs did not file an amended Complaint, and the Court dismissed the case on January 29, 2018. Lead Plaintiff filed a Notice appealing this decision on February 28, 2018. On June 13, Lead Plaintiff dismissed the appeal.